EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Caffeic acid phenethyl ester reverses doxorubicin resistance in breast cancer cells via lipid metabolism regulation at least partly by suppressing the Akt/ mTOR / SREBP1 pathway

Lu-Chang Liang, Lei Zhao, Bo Yu, Han-Xiang Hu, Xu-Hua He, Yan-Min Zhang iD

The Kaohsiung Journal of Medical Sciences · 2023

DOI: 10.1002/kjm2.12675 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2023. Verfasst von Lu-Chang Liang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Breast Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hengyang Science and Technology Planning Bureau, Hunan Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy is one of the common treatment methods for breast cancer, but chemoresistance is a severe challenge. Caffeic acid phenethyl ester (CAPE) is an active ingredient of propolis extract and has been shown to have a variety of beneficial effects, and its potential as a treatment for breast cancer is worth exploring. The effects of CAPE on doxorubicin (DOX) resistance were determined by cell counting kit‐8 (CCK‐8) assay, colony‐formation assay, and flow cytometry. Oil Red O staining and the detection of free fatty acids, triglycerides, phospholipids, and cholesterol were performed to assess the status of lipid metabolism. Quantitative polymerase chain reaction (qPCR) and western blotting were applied to investigate the molecules involved in lipid metabolism and the protein kinase B (Akt)/mammalian target of rapamycin (mTOR)/sterol regulatory element binding protein 1 (SREBP1) pathway. CAPE treatment reversed DOX resistance in breast cancer cells and suppressed their lipid metabolism. In addition, CAPE combined with DOX remarkably suppressed SREBP1 expression in part by inhibiting Akt/mTOR pathway activation. Furthermore, by inhibiting lipid metabolism, partly via the Akt/mTOR/SREBP1 pathway, CAPE ultimately reversed DOX resistance in breast cancer. Our results suggest that CAPE treatment reversed DOX resistance in breast cancer cells, at least in part by inhibiting Akt/mTOR/SREBP1 pathway‐mediated lipid metabolism, indicating that CAPE may be an effective substance to assist in the treatment of breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktBreast NeoplasmsHumansFemaleSignal TransductionSterol Regulatory Element Binding Protein 1Lipid MetabolismTOR Serine-Threonine KinasesDoxorubicinCell Line, TumorCaffeic AcidsPhenylethyl Alcohol

Stichwörter der Autor:innen

Akt/mTOR/SREBP1 pathwayCaffeic acid phenethyl esterbreast cancerdoxorubicin resistancelipid metabolism

Substanzen

Proto-Oncogene Proteins c-aktSterol Regulatory Element Binding Protein 1TOR Serine-Threonine KinasesDoxorubicincaffeic acid phenethyl esterCaffeic AcidsPhenylethyl Alcohol

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
  • Department of Pharmaceutics, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
  • Department of Urology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
  • Department of Pediatrics, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.

ORCID-Profile: Yan-Min Zhang

Förderung

  • Hengyang Science and Technology Planning Bureau
  • Hunan Provincial Health Commission

Zitieren

APA

Liang, L. C., Zhao, L., Yu, B., Hu, H. X., He, X. H., & Zhang, Y. M. (2023). Caffeic acid phenethyl ester reverses doxorubicin resistance in breast cancer cells via lipid metabolism regulation at least partly by suppressing the Akt/ mTOR / SREBP1 pathway. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.12675

Vancouver

Liang LC, Zhao L, Yu B, Hu HX, He XH, Zhang YM. Caffeic acid phenethyl ester reverses doxorubicin resistance in breast cancer cells via lipid metabolism regulation at least partly by suppressing the Akt/ mTOR / SREBP1 pathway. The Kaohsiung Journal of Medical Sciences. 2023. doi:10.1002/kjm2.12675

BibTeX
@article{Liang2023,
  author = {Liang, Lu-Chang and Zhao, Lei and Yu, Bo and Hu, Han-Xiang and He, Xu-Hua and Zhang, Yan-Min},
  title = {Caffeic acid phenethyl ester reverses doxorubicin resistance in breast cancer cells via lipid metabolism regulation at least partly by suppressing the Akt/ mTOR / SREBP1 pathway},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2023},
  doi = {10.1002/kjm2.12675}
}
Kostenlos starten →